Differential Diagnosis and Strategy

18 Differential Diagnosis and Strategy


Solitary Focus


image


Common diagnoses. Focal adenosis, adenoma/fibroadenoma, papilloma.


Rare diagnoses. Lobulus, ductal carcinoma in situ (DCIS), invasive carcinoma, intramammary lymph node, phyllodes tumor.


Strategy. See Table 18.1.



image A solitary focus on breast MRI should preferably be followed up after 6 months. The risk of this lesion being malignant is somewhat higher than that of multiple foci. Should this focus be a malignant lesion, the expected lesion size after 6 months is maximally 5–6 mm. The initial performance of an MRI-guided vacuum-assisted biopsy (VAB) can and should be avoided.


TABLE 18.1 Diagnostic work-up strategy for solitary focus























Strategy: No correlative finding on mammography or breast ultrasound


Mx/US BI-RADS1


MRI follow-upa (Figs. 18.1, 18.2, 18.3).


Strategy: Correlative finding on mammography and/or breast ultrasoundb


Mx/US BI-RADS2


Mx or US follow-upa


Mx/US BI-RADS3


Mx or US follow-upa


Mx/US BI-RADS 4


Percutaneous biopsy (US-CB or Mx-VAB)


Mx/US BI-RADS 5


Percutaneous biopsy (US-CB or Mx-VAB)


a Follow-up interval usually 6 months.


b Small lesions often not found on second-look US.


Mx: x-ray mammography.


US: ultrasonography.


US-CB: US-guided core biopsy.


Mx-VAB: stereotactic vacuum-assisted biopsy.





Multiple Foci


image


Common diagnoses. Lobuli (physiological enhancement), adenosis, adenomas/fibroadenomas.


Rare diagnoses. Papillomas, DCIS, invasive carcinoma (one of the multiple foci), multiple carcinomas, intramammary metastases.


Strategy. See Table 18.2.



image Multiple foci on breast MRI should preferably be followed up in the normal early breast cancer detection interval of 1 year. Should one of these foci be a malignant lesion, the expected lesion size after 12 months is maximally 8–10 mm. The initial performance of an MRI-guided VAB is not expedient because “one will always biopsy the wrong focus.”


TABLE 18.2 Diagnostic work-up strategy for multiple foci























Strategy: No correlative finding on mammography or breast ultrasound


Mx/US BI-RADS1


Examination at routine intervals (Figs. 18.4, 18.5, 18.6).


Strategy: Correlative finding on mammography and/or breast ultrasound


Mx/US BI-RADS2


Examination at routine intervals


Mx/US BI-RADS3


Mx or US follow-upa


Mx/US BI-RADS 4


Percutaneous biopsy (US-CB or Mx-VAB)


Mx/US BI-RADS 5


Percutaneous biopsy (US-CB or Mx-VAB)


a Follow-up interval usually 6 months.


Mx: x-ray mammography. US: ultrasonography. US-CB: US-guided core biopsy. Mx-VAB: stereotactic vacuum-assisted biopsy.





Mass Lesion


image


Common diagnoses. Adenoma/fibroadenoma, adenosis, tumorforming adenosis, carcinoma, papilloma.


Rare diagnoses. Phyllodes tumor, hamartoma, granuloma, angiomatous hyperplasia, fibrosis, intramammary lymph node.




image


Strategy. See Table 18.5.



image



Mass Lesion—Differential Diagnosis


Rim-Enhancement (Figs. 18.7, 18.8, 18.9, 18.10)



image

< div class='tao-gold-member'>

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jul 31, 2016 | Posted by in OBSTETRICS | Comments Off on Differential Diagnosis and Strategy

Full access? Get Clinical Tree

Get Clinical Tree app for offline access